STUDY OBJECTIVES: Patients with human African trypanosomiasis (sleeping sickness) due to the inoculation of Trypanosoma brucei gambiense or rhodesiense show a major disruption of the 24-hour sleep-wake distribution, accompanied by the occurrence of sleep-onset rapid-eye-movement (REM) sleep episodes, proportional to the severity of the illness. Although animal models of human African trypanosomiasis have been developed to understand the pathogenic mechanisms leading to immune alterations, the development of an animal model featuring the alterations of endogenous biologic rhythms remains a necessity. ANIMALS: Sprague-Dawley rats (N = 10) entrained to a 12:12-hour dark-light regimen. INTERVENTIONS: Rats were infected with Trypanosoma brucei brucei AnTat 1.1E and instrumented with electrocorticographic and electromyographic electrodes. Polysomnography was recorded continuously from 2 days before infection until the animal's death. MEASUREMENTS AND RESULTS: The analysis of the spontaneous sleep-wake architecture revealed an increased proportion of slow-wave sleep (SWS) and a decreased amount of wakefulness 2 days before death. Considerable sleep fragmentation was observed in the infected rats, with numerous changes in sleep-wake stages and an increased number of episodes of wakefulness and SWS. Infected rats presented a fragmented pattern of SWS and a marked reduction in the mean paradoxical-sleep (PS) latency, resulting in a considerable disruption of the PS-SWS sequences. Abnormal transitions, particularly the appearance of sleep-onset REM episodes, marked the disruption of the internal sleep structure. The electrocorticogram traces were modified during SWS, with the occurrence of abnormal hypersynchronic slow waves and a disappearance of spindles. CONCLUSION: The Trypanosoma brucei brucei-infected rat is a good model of the syndrome seen in human African trypanosomiasis, ie, the 24-hour disruption of the sleep-wake cycle and the occurrence of sleep-onset REM-like sleep episodes.
STUDY OBJECTIVES:Patients with human African trypanosomiasis (sleeping sickness) due to the inoculation of Trypanosoma brucei gambiense or rhodesiense show a major disruption of the 24-hour sleep-wake distribution, accompanied by the occurrence of sleep-onset rapid-eye-movement (REM) sleep episodes, proportional to the severity of the illness. Although animal models of human African trypanosomiasis have been developed to understand the pathogenic mechanisms leading to immune alterations, the development of an animal model featuring the alterations of endogenous biologic rhythms remains a necessity. ANIMALS: Sprague-Dawley rats (N = 10) entrained to a 12:12-hour dark-light regimen. INTERVENTIONS:Rats were infected with Trypanosoma brucei brucei AnTat 1.1E and instrumented with electrocorticographic and electromyographic electrodes. Polysomnography was recorded continuously from 2 days before infection until the animal's death. MEASUREMENTS AND RESULTS: The analysis of the spontaneous sleep-wake architecture revealed an increased proportion of slow-wave sleep (SWS) and a decreased amount of wakefulness 2 days before death. Considerable sleep fragmentation was observed in the infected rats, with numerous changes in sleep-wake stages and an increased number of episodes of wakefulness and SWS. Infected rats presented a fragmented pattern of SWS and a marked reduction in the mean paradoxical-sleep (PS) latency, resulting in a considerable disruption of the PS-SWS sequences. Abnormal transitions, particularly the appearance of sleep-onset REM episodes, marked the disruption of the internal sleep structure. The electrocorticogram traces were modified during SWS, with the occurrence of abnormal hypersynchronic slow waves and a disappearance of spindles. CONCLUSION: The Trypanosoma brucei brucei-infectedrat is a good model of the syndrome seen in human African trypanosomiasis, ie, the 24-hour disruption of the sleep-wake cycle and the occurrence of sleep-onset REM-like sleep episodes.
Authors: Filipa Rijo-Ferreira; Theresa E Bjorness; Kimberly H Cox; Alex Sonneborn; Robert W Greene; Joseph S Takahashi Journal: J Neurosci Date: 2020-10-23 Impact factor: 6.167
Authors: Stefan Mogk; Andreas Meiwes; Swetlana Shtopel; Ulrich Schraermeyer; Michael Lazarus; Bruno Kubata; Hartwig Wolburg; Michael Duszenko Journal: PLoS One Date: 2014-03-11 Impact factor: 3.240
Authors: Claudia Laperchia; Maria Palomba; Paul F Seke Etet; Jean Rodgers; Barbara Bradley; Paul Montague; Gigliola Grassi-Zucconi; Peter G E Kennedy; Marina Bentivoglio Journal: PLoS Negl Trop Dis Date: 2016-12-21
Authors: Thomas W Hopwood; Sarah Hall; Nicola Begley; Ruth Forman; Sheila Brown; Ryan Vonslow; Ben Saer; Matthew C Little; Emma A Murphy; Rebecca J Hurst; David W Ray; Andrew S MacDonald; Andy Brass; David A Bechtold; Julie E Gibbs; Andrew S Loudon; Kathryn J Else Journal: Sci Rep Date: 2018-02-28 Impact factor: 4.379
Authors: Raymond Cespuglio; Donia Amrouni; Elizabeth F Raymond; Bernard Bouteille; Alain Buguet Journal: PLoS One Date: 2019-04-17 Impact factor: 3.240
Authors: Elizabeth G Ibarra-Coronado; Ana Ma Pantaleón-Martínez; Javier Velazquéz-Moctezuma; Oscar Prospéro-García; Mónica Méndez-Díaz; Mayra Pérez-Tapia; Lenin Pavón; Jorge Morales-Montor Journal: J Immunol Res Date: 2015-08-31 Impact factor: 4.818
Authors: Katherine Figarella; Nestor L Uzcategui; Stefan Mogk; Katleen Wild; Petra Fallier-Becker; Jonas J Neher; Michael Duszenko Journal: Sci Rep Date: 2018-10-09 Impact factor: 4.379